Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Precision Health for Arrhythmogenic Cardiomyopathy

Arrhythmogenic Cardiomyopathy (ARVC) is a rare, inherited heart disease that can lead to cardiac arrest, particularly in young adults. There are specific DNA changes that can increase a person’s risk for ARVC, so it is possible for people to know they have increased risk for ARVC before they have any symptoms. The Geisinger Genomic Screening and Counseling program is using DNA data from MyCode to identify people with these ARVC DNA (gene) changes so they can get the right care at the right time.

Having an ARVC gene change does not mean a person has heart disease. In fact, many people with these gene changes may have healthy hearts. Scientists would like to learn what causes some people to develop ARVC while others do not. 

That is why Geisinger researchers are enrolling individuals with ARVC gene changes for a new research study. The researchers are collecting data, such as exercise habits and family health history. They are also using advanced medical imaging to measure the function of the heart in new ways. These data will help scientists learn more about ARVC and how to better care for people at risk for ARVC.

To learn more about this study, please email us at

Learn more about the study